Non-small cell lung cancer: NSCLC
Conditions
Interventions
None listed
Sponsors
Nippon Boehringer Ingelheim Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients Individuals who meet the following criteria (1 and 2 or 1 and 3) will be included in the study. 1.Patients who are 18-94 years old 2.Patients who were initially diagnosed as NSCLC at stage IV (self-reported) 3.Patients who are experiencing or have experienced systemic treatments (self-reported) (In qualitative study, patients diagnosed as NSCLC at stage IIIa/b/c as well as stage IV can be allowed in case of limited recruitment availability in the patient panel for the above inclusion criteria.) Caregivers Individuals who meet all the following criteria will be included in the study. - Caregivers who are 18-94 years old - Caregivers who are currently caring for an NSCLC patient - Primary caregiver (mainly responsible or sharing responsibility equally for making treatment decisions and managing finances)
Exclusion criteria
Exclusion criteria: There are not exclusion criteria in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For patients: Treatment preferences: treatment effectiveness including side effects. For caregivers: The burden of NSCLC patient's care. | — |
Secondary
| Measure | Time frame |
|---|---|
| Exploration of the burden on patients with NSCLC Examination of patient preferences for different pharmacological treatment attributes | — |
Countries
Japan
Contacts
Public ContactTatsuki Ishizuka
Nippon Boehringer Ingelheim Co., Ltd Health Economics and Outcomes Research grp, HCA strategy dept, Market Access and Healthcare Affairs
Outcome results
None listed